Rollins School of Public Health

Gilead Sciences and Meharry Medical College Highlight Five-Year Impact of Gilead COMPASS Initiative® on HIV in the Southern United States

Retrieved on: 
Friday, August 18, 2023

It details the impact of the Gilead COMPASS Initiative® – the company’s 10-year, more than $100 million collaborative initiative that seeks to eradicate underlying serious and systemic challenges that contribute to the HIV epidemic in the Southern United States.

Key Points: 
  • It details the impact of the Gilead COMPASS Initiative® – the company’s 10-year, more than $100 million collaborative initiative that seeks to eradicate underlying serious and systemic challenges that contribute to the HIV epidemic in the Southern United States.
  • The supplemental issue, The Gilead COMPASS Initiative®: Navigating HIV in the Southern U.S. by Building Capacity & Bridging Communities , features 16 articles by COMPASS grantees across the U.S. South.
  • Home to slightly more than one-third of the population, the Southern states accounted for 51% of new HIV diagnoses in 2020.
  • Large-Scale HIV Initiative – ETR Associates
    Operationalizing Equity-centered Implementation Through Person-centered Care Capacity-building with HIV Service Organizations: The SUSTAIN Approach – Eastern Connecticut State University

Lenz, Inc. Names Mike Killeen President and CEO

Retrieved on: 
Tuesday, May 9, 2023

ATLANTA, May 9, 2023 /PRNewswire/ -- Lenz, Inc., has named Mike Killeen its new president and CEO. Mike joined Lenz in 2002 and previously served as Vice President of Marketing.

Key Points: 
  • ATLANTA, May 9, 2023 /PRNewswire/ -- Lenz, Inc., has named Mike Killeen its new president and CEO.
  • Mike joined Lenz in 2002 and previously served as Vice President of Marketing.
  • The new leadership team includes Christine Mahin as Vice President, Ricky Pattillo as Engineering Director, Rachel Cushing as Media Director, and Scott Sanders as Associate Creative Director.
  • "It is a privilege and an honor to assume this new role and help lead Lenz towards a very bright future," Killeen said.

Episcopal Relief & Development Receives Research Grant from Conrad N. Hilton Foundation to Study Early Childhood Development Work

Retrieved on: 
Thursday, March 16, 2023

NEW YORK, March 16, 2023 /PRNewswire-PRWeb/ -- Episcopal Relief & Development has been awarded a research grant from the Conrad N. Hilton Foundation to study an adaptation to the organization's Moments That Matter® (MTM) early childhood development program partnership in Kenya.

Key Points: 
  • NEW YORK, March 16, 2023 /PRNewswire-PRWeb/ -- Episcopal Relief & Development has been awarded a research grant from the Conrad N. Hilton Foundation to study an adaptation to the organization's Moments That Matter ® (MTM) early childhood development program partnership in Kenya.
  • "We deeply appreciate the continued partnership of the Conrad N. Hilton Foundation and its commitment to research, learning and adaptation with Moments That Matter®," said Dawn Murdock, Director, Strategic Learning & Program Resources, Episcopal Relief & Development.
  • "This grant supports testing and learning from the 18-month program adaptation carried out by our partner, Anglican Development Services-Nyanza, in Kenya.
  • The program, which is Episcopal Relief & Development's flagship integrated early childhood development partnership, is a community-led approach aligned with the Nurturing Care Framework .

Chemical Insights Research Institute and Emory University's Rollins School of Public Health Team to Study the Human Health Impact of PFAS Chemical Exposure

Retrieved on: 
Tuesday, February 21, 2023

ATLANTA, Feb. 21, 2023 /PRNewswire/ -- Chemical Insights Research Institute (CIRI) of UL Research Institutes and Emory University's Rollins School of Public Health have announced upcoming research to study human exposure to per- and polyfluoroalkyl substances (PFAS). Data from the Centers for Disease Control and Prevention (CDC) show that approximately 97% of Americans have detectable PFAS levels in their blood. The joint study aims to understand how this exposure occurs and the potential health consequences.

Key Points: 
  • ATLANTA, Feb. 21, 2023 /PRNewswire/ -- Chemical Insights Research Institute (CIRI) of UL Research Institutes and Emory University's Rollins School of Public Health have announced upcoming research to study human exposure to per- and polyfluoroalkyl substances (PFAS).
  • The joint study aims to understand how this exposure occurs and the potential health consequences.
  • Insights gained will assist in understanding potential health impacts and how material design, and use, contribute to human exposure risks.
  • The cutting-edge PFAS research that CIRI and the Rollins School of Public Health is conducting supports UL Research Institutes' goal to advance safety science for societal well- being.

Hispanic Health Coalition of Georgia partners with the Community Health Assessment course from the Rollins School of Public Health at Emory University for a Rapid Assessment project

Retrieved on: 
Sunday, December 11, 2022

ATLANTA, Dec. 11, 2022 /PRNewswire/ -- Rollins School of Public Health, Emory University -- A Rapid Community Health Assessment (RCHA) of Hispanic/Latin population in northeast Georgia was conducted by five Emory University Master of Public Health students under the direction of the HHCGA and faculty of the Rollins School of Public Health. Chloe Billstrom, Mia Carvalho Guimaraes, Emma Halper, Chloe Hultman and Vanessa Orduna Zarazua were assigned as health assessors based on criteria that included their Spanish speaking capacity, interest, and experience in the subject matter. Claudia E. Ordóñez, Adjunct Assistant Professor at Rollins School of Public Health and the faculty member teaching the CHA course and guiding the RCHA project, began the RCHA findings presentation by welcoming community partners, guests and students and expressing her appreciation of the partnership with the HHCGA, and the hard work of the assessment team as part of this partnership. Prof. Ordóñez made this important statement, "Ongoing efforts to improve and facilitate better health outcomes in the Hispanic/Latin community highlighted the need for health care providers and programs to have relevant and accurate knowledge of the community's health needs and assets at a hyperlocal level, while supporting efforts for greater community awareness of health services available. By implementing the rapid health assessment we gained important insights through community members responses, as captured by the Rollins team. We are eager to hear the suggested actions for improvements based on the team's conclusions and recommendations."

Key Points: 
  • The Hispanic Health Coalition of Georgia (HHCGA) partnered with the Community Health Assessment (CHA) course from the Rollins School of Public Health at Emory University for a Rapid Assessment project which directly speaks to the effectiveness of current health strategies for our Hispanic/Latino community.
  • ATLANTA, Dec. 11, 2022 /PRNewswire/ -- Rollins School of Public Health, Emory University-- A Rapid Community Health Assessment (RCHA) of Hispanic/Latin population in northeast Georgia was conducted by five Emory University Master of Public Health students under the direction of the HHCGA and faculty of the Rollins School of Public Health.
  • By implementing the rapid health assessment we gained important insights through community members responses, as captured by the Rollins team.
  • As an expert in community health promotion, education, policy and health advocacy, HHCGA creates high-quality, culturally sensitive, and linguistically appropriate health care and prevention services for their community.

Amy Rollins Kreisler Appointed to the Marine Products Corporation Board of Directors

Retrieved on: 
Monday, October 31, 2022

ATLANTA, Oct. 31, 2022 /PRNewswire/ -- Marine Products Corporation (NYSE: MPX) announced today the appointment of Amy Rollins Kreisler to the Board of Directors of the Company.

Key Points: 
  • ATLANTA, Oct. 31, 2022 /PRNewswire/ -- Marine Products Corporation (NYSE: MPX) announced today the appointment of Amy Rollins Kreisler to the Board of Directors of the Company.
  • Mrs. Kreisler is a Trustee on The Lovett School Board of Trustees and also serves on the Executive Committee.
  • Richard A. Hubbell, Chairman of the Board of Marine Products Corporation stated, "Amy Kreisler has been beneficial to the boards on which she has served.
  • Marine Products Corporation is a leading manufacturer of fiberglass boats under the brand names Chaparral and Robalo.

New Analysis Finds Accelerated Approval Drugs Do Not Drive Medicaid Spending

Retrieved on: 
Friday, June 3, 2022

The Partnership to Fight Chronic Disease (PFCD) today released, Quantifying Impact of Accelerated Approval Drugs on Medicaid Spending: An Update through 2020 and State-Level Analysis , an updated and enhanced economic analysis examining the impact of the Food and Drug Administrations (FDA) accelerated approval pathway on Medicaid spending.

Key Points: 
  • The Partnership to Fight Chronic Disease (PFCD) today released, Quantifying Impact of Accelerated Approval Drugs on Medicaid Spending: An Update through 2020 and State-Level Analysis , an updated and enhanced economic analysis examining the impact of the Food and Drug Administrations (FDA) accelerated approval pathway on Medicaid spending.
  • The findings were simultaneously published in a Health Affairs Forefront commentary titled " Accelerated Approval Drugs are Not Driving Medicaid Spending .
  • At the national level, spending on accelerated approval drugs also accounted for just 0.5% of overall growth in national Medicaid spending between 2007 and 2020.
  • Accelerated approval drugs accounted for less than 1% of the growth in Medicaid spending in 48 states and the District of Columbia.

LUNGevity Names Maisha Standifer, PhD, MPH, LUNGevity Community Scholar-in-Residence

Retrieved on: 
Wednesday, April 27, 2022

WASHINGTON, April 27, 2022 /PRNewswire/ -- LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, welcomes Maisha Standifer, PhD, MPH, as its first Community Scholar-in-Residence. In this new position, Dr. Standifer will help develop relationships with organizational, academic, and community-based research partners and will also be instrumental in executing LUNGevity's Annual Lung Cancer Health Equity Roundtable.

Key Points: 
  • WASHINGTON, April 27, 2022 /PRNewswire/ -- LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, welcomes Maisha Standifer, PhD, MPH, as its first Community Scholar-in-Residence.
  • She is also a co-investigator on multiple federally funded studies and a lecturer at Morehouse College and Emory University.
  • "With 15 years of examining health inequalities both globally and domestically, Maisha will be a welcome addition to LUNGevity," explained Andrea Ferris, the foundation's president and CEO.
  • The organization provides an active community for patients and survivorsand those who help them live longer and better lives.

In landmark shift, ONE® brand condoms are first to receive FDA approval for "safe and effective use" label for anal sex

Retrieved on: 
Wednesday, February 23, 2022

ONE will become the first condom brand ever to be labeled for safe and effective use for anal sex.

Key Points: 
  • ONE will become the first condom brand ever to be labeled for safe and effective use for anal sex.
  • ONE and myONE condoms are the first condom brand ever to be labeled for safe and effective use during anal sex.
  • This is because no data on condom safety for anal sex has been previously provided to the FDA.
  • Utility of a US Food and Drug Administration (FDA) label indication for condoms for anal sex.

The Global Health Crisis Coordination Center’s Information Equity Project “COVIED” Announces the Roll-Out of Innovative Tools and Resources for Enhancing COVID-19 Vaccine Uptake

Retrieved on: 
Thursday, January 27, 2022

It aims to promote COVID vaccine uptake by providing tailored messaging and tools to those populations through community engagement and widespread message dissemination.

Key Points: 
  • It aims to promote COVID vaccine uptake by providing tailored messaging and tools to those populations through community engagement and widespread message dissemination.
  • Accurate information, delivered in the right way by known and trusted messengers leads to greater community-level vaccine acceptance, which reduces illness and saves lives.
  • The COVIED project has been successfully implemented as part of GHC3s community outreach in underserved and under-vaccinated communities.
  • GHC3, a division of the Center for Global Health Innovation, maintained primary oversight responsibility for project implementation.